Physician_Profile_ID,Category,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State,Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID,Total_Amount_of_Payment_USDollars,Date_of_Payment,Category,Record_ID
26940,GNRL,"COMSORT, Inc",MD,100000000055,150.00,11/07/2013,GNRL,24303215
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,125.12,01/12/2015,GNRL,260115914
26940,GNRL,"COMSORT, Inc",MD,100000000055,125.00,06/05/2014,GNRL,201916640
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,87.18,10/29/2013,GNRL,100452576
26940,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,71.56,05/28/2015,GNRL,337466410
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,68.50,03/05/2014,GNRL,148486322
26940,GNRL,"Astellas Pharma US Inc",IL,100000000137,66.60,11/19/2013,GNRL,101702094
26940,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,61.18,11/17/2015,GNRL,275455526
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,60.34,01/15/2014,GNRL,150914536
26940,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,59.95,02/27/2015,GNRL,318728104
26940,GNRL,"Novo Nordisk Inc",NJ,100000000144,48.31,07/14/2015,GNRL,270166664
26940,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,45.43,07/17/2014,GNRL,156495508
26940,GNRL,"Amgen Inc.",CA,100000000203,44.69,10/14/2015,GNRL,297616922
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,36.23,08/27/2013,GNRL,100452580
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,35.59,08/08/2013,GNRL,101185538
26940,GNRL,"Novo Nordisk Inc",NJ,100000000144,32.99,10/07/2014,GNRL,162150260
26940,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,26.21,12/22/2015,GNRL,275455536
26940,GNRL,"Novo Nordisk Inc",NJ,100000000144,24.85,09/04/2013,GNRL,32248889
26940,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,23.06,09/30/2013,GNRL,104452132
26940,GNRL,"Horizon Pharma USA, Inc.",IL,100000005713,22.88,08/27/2013,GNRL,102026346
26940,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,22.68,09/01/2015,GNRL,275455560
26940,GNRL,"Horizon Pharma plc","",100000131389,21.89,01/28/2015,GNRL,281935666
26940,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,21.72,11/19/2014,GNRL,274407949
26940,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,21.50,10/23/2014,GNRL,248148210
26940,GNRL,"EISAI INC.",NJ,100000000136,21.22,07/08/2015,GNRL,338045060
26940,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,21.07,09/09/2014,GNRL,198549060
26940,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,21.00,06/10/2014,GNRL,156495512
26940,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,20.87,12/15/2015,GNRL,275455538
26940,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,20.75,11/25/2014,GNRL,196603844
26940,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,20.75,07/31/2015,GNRL,319408928
26940,GNRL,"AbbVie, Inc.",IL,100000000204,20.74,11/11/2013,GNRL,104616206
26940,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,20.58,10/30/2015,GNRL,290716170
26940,GNRL,"Novo Nordisk Inc",NJ,100000000144,20.42,10/06/2015,GNRL,270023554
26940,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,20.30,10/16/2015,GNRL,275455562
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,20.23,09/10/2013,GNRL,100942712
26940,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,20.18,04/22/2015,GNRL,319126389
26940,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,19.84,06/23/2015,GNRL,275455554
26940,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,19.77,08/04/2014,GNRL,194281410
26940,GNRL,"Pfizer Inc.",NY,100000000286,19.65,03/07/2014,GNRL,206993120
26940,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,19.58,09/27/2015,GNRL,275455556
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,19.47,05/22/2015,GNRL,260116374
26940,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,19.47,07/16/2015,GNRL,319366554
26940,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,19.41,11/21/2013,GNRL,103299766
26940,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,19.37,07/10/2015,GNRL,326077234
26940,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,19.09,10/07/2014,GNRL,156495516
26940,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,19.02,09/16/2014,GNRL,156495502
26940,GNRL,"Pfizer Inc.",NY,100000000286,18.93,07/21/2014,GNRL,206228044
26940,GNRL,"Teva Pharmaceuticals USA, Inc.",PA,100000000141,18.83,06/15/2015,GNRL,293817648
26940,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,18.71,06/05/2014,GNRL,194281405
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,18.61,07/22/2014,GNRL,147789118
26940,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,18.59,06/16/2015,GNRL,290716180
26940,GNRL,"Arbor Pharmaceuticals, Inc.",GA,100000005507,18.58,10/05/2015,GNRL,283383756
26940,GNRL,"Pfizer Inc.",NY,100000000286,18.47,08/18/2015,GNRL,322360850
26940,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,18.36,12/04/2014,GNRL,194281446
26940,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,18.33,02/02/2015,GNRL,275455544
26940,GNRL,"LILLY USA, LLC",IN,100000000066,18.13,11/12/2013,GNRL,100089182
26940,GNRL,"Horizon Pharma plc","",100000131389,18.01,03/09/2015,GNRL,281935668
26940,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,17.94,04/07/2015,GNRL,290716190
26940,GNRL,"Novo Nordisk Inc",NJ,100000000144,17.93,03/06/2015,GNRL,269614230
26940,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,17.86,09/07/2015,GNRL,275455558
26940,GNRL,"Teva Pharmaceuticals USA, Inc.",PA,100000000141,17.84,08/28/2014,GNRL,173427892
26940,GNRL,"Sunovion Pharmaceuticals Inc.",MA,100000000254,17.72,08/20/2015,GNRL,321454718
26940,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,17.66,04/08/2015,GNRL,319366472
26940,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,17.63,06/02/2014,GNRL,194281435
26940,GNRL,"Novo Nordisk Inc",NJ,100000000144,17.47,11/10/2015,GNRL,270099918
26940,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,17.33,02/05/2014,GNRL,194281388
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,17.32,10/08/2014,GNRL,150566622
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,17.32,01/27/2014,GNRL,147789076
26940,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,17.32,01/05/2015,GNRL,336824230
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,17.26,07/01/2014,GNRL,147789034
26940,GNRL,"Lilly USA, LLC",IN,100000000066,17.26,08/12/2015,GNRL,267993234
26940,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,17.24,02/18/2015,GNRL,290716198
26940,GNRL,"LILLY USA, LLC",IN,100000000066,17.13,10/31/2014,GNRL,137728514
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,16.97,12/18/2015,GNRL,260100252
26940,GNRL,"Teva Pharmaceuticals USA, Inc.",PA,100000000141,16.96,11/19/2015,GNRL,293817650
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,16.88,05/21/2014,GNRL,148830376
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,16.85,11/19/2013,GNRL,100452564
26940,GNRL,"Mylan Specialty L.P.",WV,100000005573,16.83,03/05/2015,GNRL,320222270
26940,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,16.81,10/21/2015,GNRL,290716173
26940,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,16.81,12/11/2015,GNRL,319366680
26940,GNRL,"Horizon Pharma plc","",100000131389,16.74,03/25/2015,GNRL,281935670
26940,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,16.67,09/30/2014,GNRL,196603848
26940,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,16.61,03/04/2015,GNRL,336920988
26940,GNRL,"Novo Nordisk Inc",NJ,100000000144,16.56,12/18/2014,GNRL,162350918
26940,GNRL,"Amgen Inc.",CA,100000000203,16.55,01/14/2014,GNRL,138214884
26940,GNRL,"Novo Nordisk Inc",NJ,100000000144,16.54,11/14/2013,GNRL,32248891
26940,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,16.53,01/28/2014,GNRL,196603860
26940,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,16.50,10/02/2015,GNRL,290140386
26940,GNRL,"Pfizer Inc.",NY,100000000286,16.37,10/27/2015,GNRL,323523864
26940,GNRL,"Astellas Pharma US Inc",IL,100000000137,16.36,05/13/2014,GNRL,168659620
26940,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,16.34,10/22/2014,GNRL,194281416
26940,GNRL,"Actavis Pharma Inc",NJ,100000010642,16.30,05/08/2015,GNRL,339588266
26940,GNRL,"Actavis Pharma Inc",NJ,100000010642,16.30,05/08/2015,GNRL,339588268
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,16.21,12/30/2014,GNRL,150243378
26940,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,16.19,06/19/2014,GNRL,196603850
26940,GNRL,"Novo Nordisk Inc",NJ,100000000144,16.19,03/24/2015,GNRL,269642572
26940,GNRL,"Novo Nordisk Inc",NJ,100000000144,16.12,05/29/2015,GNRL,269757356
26940,GNRL,"Pfizer Inc.",NY,100000000286,16.10,10/21/2014,GNRL,207175046
26940,GNRL,"Novo Nordisk Inc",NJ,100000000144,16.07,03/23/2015,GNRL,269669532
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,16.05,10/09/2014,GNRL,147789114
26940,GNRL,"Astellas Pharma US Inc",IL,100000000137,16.02,08/07/2014,GNRL,168414546
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,16.02,01/23/2015,GNRL,260063956
26940,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,16.00,12/08/2015,GNRL,318589174
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,15.80,04/16/2014,GNRL,150376420
26940,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,15.80,02/09/2015,GNRL,319366420
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,15.78,02/27/2014,GNRL,150615842
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,15.75,03/06/2014,GNRL,147789046
26940,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,15.69,09/25/2015,GNRL,331997819
26940,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,15.63,09/12/2013,GNRL,13977097
26940,GNRL,"Pfizer Inc.",NY,100000000286,15.59,04/29/2015,GNRL,323867628
26940,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,15.58,11/20/2013,GNRL,14285761
26940,GNRL,"Pfizer Inc.",NY,100000000286,15.57,07/13/2015,GNRL,323273598
26940,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,15.47,03/04/2014,GNRL,248148208
26940,GNRL,"Novo Nordisk Inc",NJ,100000000144,15.43,11/06/2015,GNRL,270099888
26940,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,15.41,01/20/2014,GNRL,156495500
26940,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,15.41,11/04/2014,GNRL,156495518
26940,GNRL,"AbbVie, Inc.",IL,100000000204,15.36,09/23/2014,GNRL,189514706
26940,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,15.34,06/04/2015,GNRL,319366499
26940,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,15.30,02/10/2015,GNRL,336874598
26940,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,15.22,08/25/2015,GNRL,319162456
26940,GNRL,"Mylan Specialty L.P.",WV,100000005573,15.10,03/13/2014,GNRL,186069570
26940,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,15.05,02/12/2015,GNRL,336884264
26940,GNRL,"Novo Nordisk Inc",NJ,100000000144,15.04,06/04/2014,GNRL,161699949
26940,GNRL,"LILLY USA, LLC",IN,100000000066,15.02,09/25/2014,GNRL,137894708
26940,GNRL,"Novo Nordisk Inc",NJ,100000000144,15.00,07/17/2014,GNRL,162437476
26940,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,14.93,12/17/2014,GNRL,198549032
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,14.92,10/07/2014,GNRL,150699670
26940,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,14.92,04/28/2015,GNRL,337104426
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,14.91,07/07/2015,GNRL,260098394
26940,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,14.89,10/28/2014,GNRL,156495504
26940,GNRL,"Astellas Pharma US Inc",IL,100000000137,14.89,12/21/2015,GNRL,295075678
26940,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,14.88,10/29/2015,GNRL,318727213
26940,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,14.83,11/27/2013,GNRL,14284202
26940,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,14.78,11/05/2014,GNRL,156495506
26940,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,14.75,09/08/2014,GNRL,198549058
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,14.69,09/19/2015,GNRL,260055252
26940,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,14.67,12/23/2014,GNRL,156495520
26940,GNRL,"Pfizer Inc.",NY,100000000286,14.66,09/21/2015,GNRL,323493464
26940,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,14.61,02/02/2015,GNRL,319366424
26940,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,14.60,11/12/2015,GNRL,275455534
26940,GNRL,"Novo Nordisk Inc",NJ,100000000144,14.60,04/27/2015,GNRL,269708590
26940,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,14.59,11/23/2015,GNRL,319366650
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,14.54,02/12/2014,GNRL,147789067
26940,GNRL,"AbbVie, Inc.",IL,100000000204,14.54,01/09/2014,GNRL,189116848
26940,GNRL,"Lilly USA, LLC",IN,100000000066,14.54,06/24/2015,GNRL,267993230
26940,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,14.51,04/20/2015,GNRL,325938552
26940,GNRL,"Pfizer Inc.",NY,100000000286,14.49,03/19/2014,GNRL,207234452
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,14.48,08/06/2013,GNRL,100452578
26940,GNRL,"Pfizer Inc.",NY,100000000286,14.36,01/03/2014,GNRL,206989770
26940,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,14.35,05/20/2015,GNRL,275455552
26940,GNRL,"Eisai Inc.",NJ,100000000136,14.29,05/14/2014,GNRL,184612962
26940,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,14.25,03/26/2014,GNRL,196603854
26940,GNRL,"Lilly USA, LLC",IN,100000000066,14.25,01/27/2015,GNRL,267993236
26940,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,14.24,04/13/2015,GNRL,290716188
26940,GNRL,"Ironwood Pharmaceuticals, Inc",MA,100000000245,14.17,11/24/2015,GNRL,325007382
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,14.15,04/02/2014,GNRL,148441428
26940,GNRL,"Pfizer Inc.",NY,100000000286,14.13,12/30/2015,GNRL,323112626
26940,GNRL,"Astellas Pharma US Inc",IL,100000000137,14.09,11/30/2015,GNRL,295049996
26940,GNRL,"AbbVie, Inc.",IL,100000000204,14.02,05/01/2014,GNRL,189299550
26940,GNRL,"Mylan Specialty L.P.",WV,100000005573,14.00,10/31/2013,GNRL,102247858
26940,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,14.00,10/16/2013,GNRL,14266199
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.92,01/12/2015,GNRL,260120284
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.91,09/12/2014,GNRL,149850416
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.90,08/08/2013,GNRL,100891678
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.89,03/03/2015,GNRL,260024586
26940,GNRL,"Actavis Pharma Inc",NJ,100000010642,13.89,11/11/2015,GNRL,339431392
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.86,01/08/2015,GNRL,260071802
26940,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,13.86,08/17/2015,GNRL,319366569
26940,GNRL,"Lilly USA, LLC",IN,100000000066,13.85,04/21/2015,GNRL,267993228
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.82,08/13/2014,GNRL,148222094
26940,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,13.74,02/26/2014,GNRL,196603858
26940,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,13.73,05/11/2015,GNRL,337143912
26940,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,13.68,03/13/2015,GNRL,275455532
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.66,02/24/2015,GNRL,260105350
26940,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,13.66,08/11/2015,GNRL,275455530
26940,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,13.60,01/23/2015,GNRL,336832712
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,13.59,12/02/2013,GNRL,100452574
26940,GNRL,"Novo Nordisk Inc",NJ,100000000144,13.59,02/10/2014,GNRL,160702568
26940,GNRL,"Horizon Pharma USA, Inc.",IL,100000005713,13.58,04/08/2014,GNRL,207980264
26940,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,13.56,11/05/2015,GNRL,332141779
26940,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,13.51,12/02/2015,GNRL,275455524
26940,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,13.51,01/13/2015,GNRL,319366371
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.50,04/23/2014,GNRL,150372092
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,13.46,08/21/2013,GNRL,100452572
26940,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,13.46,06/22/2015,GNRL,319366539
26940,GNRL,"Novo Nordisk Inc",NJ,100000000144,13.40,02/07/2014,GNRL,160709100
26940,GNRL,"Pfizer Inc.",NY,100000000286,13.36,10/02/2014,GNRL,206384332
26940,GNRL,"Actavis Pharma Inc",NJ,100000010642,13.36,03/30/2015,GNRL,339400754
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.35,03/21/2014,GNRL,148340888
26940,GNRL,"Teva Pharmaceuticals USA, Inc.",PA,100000000141,13.33,03/27/2014,GNRL,173427886
26940,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,13.28,03/03/2014,GNRL,196603856
26940,GNRL,"Mylan Specialty L.P.",WV,100000005573,13.21,09/30/2015,GNRL,320372742
26940,GNRL,"Pfizer Inc.",NY,100000000286,13.16,09/01/2015,GNRL,322587710
26940,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,13.12,05/27/2015,GNRL,275455550
26940,GNRL,"Pfizer Inc.",NY,100000000286,13.12,06/12/2015,GNRL,322518756
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,13.02,12/03/2013,GNRL,101126568
26940,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,13.02,03/11/2015,GNRL,337034340
26940,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,13.00,10/07/2013,GNRL,23817342
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,13.00,11/03/2014,GNRL,147789100
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.96,07/14/2015,GNRL,260099462
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.91,09/09/2013,GNRL,100923404
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.89,10/03/2013,GNRL,101097310
26940,GNRL,"Mylan Specialty L.P.",WV,100000005573,12.85,09/22/2014,GNRL,186092432
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,12.85,12/14/2015,GNRL,331132055
26940,GNRL,"Lilly USA, LLC",IN,100000000066,12.84,12/09/2015,GNRL,267993226
26940,GNRL,"Lilly USA, LLC",IN,100000000066,12.82,05/13/2015,GNRL,267993212
26940,GNRL,"Novo Nordisk Inc",NJ,100000000144,12.76,10/15/2013,GNRL,32248890
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.75,08/16/2013,GNRL,101005160
26940,GNRL,"Actavis Pharma Inc",NJ,100000010642,12.72,07/22/2015,GNRL,339364884
26940,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,12.70,01/22/2014,GNRL,196603862
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.69,10/23/2013,GNRL,100959680
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.69,11/11/2014,GNRL,150851204
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.68,07/14/2014,GNRL,148536674
26940,GNRL,"Pfizer Inc.",NY,100000000286,12.64,04/03/2014,GNRL,207252522
26940,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,12.63,05/19/2015,GNRL,319366486
26940,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,12.60,04/01/2014,GNRL,194281424
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.59,03/25/2014,GNRL,148700622
26940,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,12.57,05/27/2015,GNRL,290716184
26940,GNRL,"Pfizer Inc.",NY,100000000286,12.55,07/23/2014,GNRL,206806980
26940,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,12.52,05/01/2015,GNRL,275455548
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.51,09/16/2015,GNRL,260059152
26940,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,12.50,08/20/2014,GNRL,198549064
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.43,01/15/2014,GNRL,150296832
26940,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,12.43,11/24/2014,GNRL,198549050
26940,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,12.41,02/17/2015,GNRL,318961493
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,12.33,11/17/2014,GNRL,147789110
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.28,02/13/2014,GNRL,148293396
26940,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,12.24,03/24/2014,GNRL,156495510
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.24,06/26/2015,GNRL,260025880
26940,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,12.22,01/07/2014,GNRL,187704230
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.22,10/28/2015,GNRL,260076146
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.21,12/11/2013,GNRL,101153590
26940,GNRL,"Astellas Pharma US Inc",IL,100000000137,12.18,03/02/2015,GNRL,294762408
26940,GNRL,"Astellas Pharma US Inc",IL,100000000137,12.14,08/31/2015,GNRL,295292786
26940,GNRL,"Ironwood Pharmaceuticals, Inc",MA,100000000245,12.13,08/14/2014,GNRL,191608600
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,12.03,12/23/2013,GNRL,100930526
26940,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,12.03,08/04/2015,GNRL,326240586
26940,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,12.02,04/14/2014,GNRL,198549081
26940,GNRL,"Actavis Pharma Inc",NJ,100000010642,12.01,01/14/2015,GNRL,339312494
26940,GNRL,"Actavis Pharma Inc",NJ,100000010642,12.01,09/10/2015,GNRL,339312498
26940,GNRL,"Actavis Pharma Inc",NJ,100000010642,12.01,09/10/2015,GNRL,339312502
26940,GNRL,"Lilly USA, LLC",IN,100000000066,12.00,12/16/2015,GNRL,267993208
26940,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,12.00,07/23/2015,GNRL,290716176
26940,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,12.00,12/16/2015,GNRL,319807681
26940,GNRL,"Astellas Pharma US Inc",IL,100000000137,11.99,06/03/2015,GNRL,295198550
26940,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,11.98,10/13/2015,GNRL,319366630
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,11.87,04/29/2014,GNRL,147789062
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,11.85,12/18/2013,GNRL,171860024
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.79,10/30/2013,GNRL,101148770
26940,GNRL,"Astellas Pharma US Inc",IL,100000000137,11.78,11/06/2013,GNRL,101684110
26940,GNRL,"Novo Nordisk Inc",NJ,100000000144,11.77,12/07/2015,GNRL,270105750
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.75,12/02/2014,GNRL,148676882
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.71,09/11/2014,GNRL,148541532
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.71,05/01/2015,GNRL,260091504
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.70,03/31/2014,GNRL,149772154
26940,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,11.69,07/31/2014,GNRL,156495514
26940,GNRL,"LILLY USA, LLC",IN,100000000066,11.68,01/30/2014,GNRL,137878278
26940,GNRL,"Lilly USA, LLC",IN,100000000066,11.64,10/15/2015,GNRL,267993232
26940,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,11.59,02/24/2015,GNRL,325874926
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.58,11/14/2014,GNRL,150782962
26940,GNRL,"Lilly USA, LLC",IN,100000000066,11.55,11/19/2015,GNRL,267993222
26940,GNRL,"AbbVie, Inc.",IL,100000000204,11.55,07/27/2015,GNRL,316988922
26940,GNRL,"Actavis Pharma Inc",NJ,100000010642,11.54,03/19/2015,GNRL,339261092
26940,GNRL,"Lilly USA, LLC",IN,100000000066,11.52,11/20/2015,GNRL,267993206
26940,GNRL,"Ironwood Pharmaceuticals, Inc",MA,100000000245,11.51,03/18/2014,GNRL,191608598
26940,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,11.51,06/29/2015,GNRL,331719337
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,11.47,07/08/2014,GNRL,147789058
26940,GNRL,"Novo Nordisk Inc",NJ,100000000144,11.41,11/17/2015,GNRL,270073624
26940,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,11.39,04/24/2015,GNRL,275455546
26940,GNRL,"Astellas Pharma US Inc",IL,100000000137,11.36,08/29/2013,GNRL,101680148
26940,GNRL,"Pfizer Inc.",NY,100000000286,11.35,09/03/2013,GNRL,205956130
26940,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,11.33,08/15/2013,GNRL,103299764
26940,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,11.23,02/19/2015,GNRL,290716194
26940,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,11.18,09/15/2015,GNRL,337331220
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,11.16,04/07/2014,GNRL,147789054
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,11.15,10/09/2013,GNRL,100452562
26940,GNRL,"Daiichi Sankyo Inc.",NJ,100000000195,11.06,09/11/2015,GNRL,326207560
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,11.05,11/18/2015,GNRL,260118656
26940,GNRL,"Novo Nordisk Inc",NJ,100000000144,11.00,03/10/2015,GNRL,269646062
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.95,03/31/2015,GNRL,260118088
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,10.95,01/15/2015,GNRL,330162207
26940,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,10.90,01/16/2014,GNRL,198549084
26940,GNRL,"Novo Nordisk Inc",NJ,100000000144,10.89,08/03/2015,GNRL,269848600
26940,GNRL,"LILLY USA, LLC",IN,100000000066,10.87,11/12/2014,GNRL,137758258
26940,GNRL,"Actavis Pharma Inc",NJ,100000010642,10.85,07/21/2015,GNRL,339207102
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.84,02/03/2015,GNRL,260063226
26940,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,10.83,08/14/2013,GNRL,104331438
26940,GNRL,"LILLY USA, LLC",IN,100000000066,10.82,03/11/2014,GNRL,137585590
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,10.81,02/14/2014,GNRL,201062995
26940,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,10.77,01/19/2015,GNRL,275455542
26940,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,10.73,04/24/2015,GNRL,331617723
26940,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,10.67,06/05/2015,GNRL,319594388
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,10.65,09/23/2013,GNRL,100452560
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.65,09/24/2014,GNRL,148973584
26940,GNRL,"Lilly USA, LLC",IN,100000000066,10.65,07/30/2015,GNRL,267993214
26940,GNRL,"Lilly USA, LLC",IN,100000000066,10.65,02/04/2015,GNRL,267993218
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,10.65,01/21/2015,GNRL,330108757
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,10.64,10/23/2014,GNRL,147789096
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.60,07/30/2014,GNRL,148480922
26940,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,10.58,12/02/2014,GNRL,198549046
26940,GNRL,"Lilly USA, LLC",IN,100000000066,10.49,10/17/2015,GNRL,267993204
26940,GNRL,"Novo Nordisk Inc",NJ,100000000144,10.45,07/01/2015,GNRL,269807042
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.44,04/21/2014,GNRL,149557504
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,10.42,12/04/2013,GNRL,100452558
26940,GNRL,"AbbVie, Inc.",IL,100000000204,10.40,02/25/2015,GNRL,308998062
26940,GNRL,"Pfizer Inc.",NY,100000000286,10.38,06/26/2014,GNRL,205468098
26940,GNRL,"Pfizer Inc.",NY,100000000286,10.38,03/12/2015,GNRL,323057758
26940,GNRL,"AstraZeneca Pharmaceuticals LP",DE,100000000146,10.36,04/24/2014,GNRL,150604000
26940,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,10.34,05/04/2015,GNRL,319793218
26940,GNRL,"Actavis Pharma Inc",NJ,100000010642,10.34,04/06/2015,GNRL,339159166
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,10.31,11/04/2013,GNRL,100452570
26940,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,10.27,10/27/2014,GNRL,196603846
26940,GNRL,"Amgen Inc.",CA,100000000203,10.27,10/19/2015,GNRL,297616916
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,10.21,08/13/2013,GNRL,100452556
26940,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,10.19,03/12/2014,GNRL,194281396
26940,GNRL,"E.R. Squibb & Sons, L.L.C.",NJ,100000005499,10.13,08/30/2013,GNRL,13977098
26940,GNRL,"Actavis Pharma Inc",NJ,100000010642,10.12,01/20/2015,GNRL,339147342
26940,GNRL,"Novo Nordisk Inc",NJ,100000000144,10.09,08/18/2014,GNRL,161979136
26940,GNRL,"Lilly USA, LLC",IN,100000000066,10.09,07/24/2015,GNRL,267993224
26940,GNRL,"LILLY USA, LLC",IN,100000000066,10.08,08/22/2013,GNRL,100144088
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,10.07,08/20/2013,GNRL,171860022
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,10.07,07/07/2014,GNRL,201896906
26940,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,10.06,04/17/2014,GNRL,198549078
26940,GNRL,"Actavis Pharma Inc",NJ,100000010642,10.06,08/05/2015,GNRL,339145802
26940,GNRL,"Pfizer Inc.",NY,100000000286,10.02,08/19/2013,GNRL,205299846
26940,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,10.00,07/02/2015,GNRL,337244414
26940,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,9.95,10/08/2015,GNRL,319615394
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,9.94,07/20/2015,GNRL,330678429
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,9.93,11/18/2014,GNRL,147789132
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,9.92,02/25/2014,GNRL,147789042
26940,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,9.90,06/19/2015,GNRL,319025616
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,9.90,02/11/2015,GNRL,330175233
26940,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,9.70,06/11/2014,GNRL,198549072
26940,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,9.69,05/07/2014,GNRL,198549076
26940,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,9.67,08/05/2013,GNRL,104312196
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,9.61,05/18/2015,GNRL,330514165
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,9.51,10/13/2014,GNRL,147789092
26940,GNRL,"Novo Nordisk Inc",NJ,100000000144,9.40,07/02/2014,GNRL,161545942
26940,GNRL,"Pfizer Inc.",NY,100000000286,9.40,08/12/2014,GNRL,206473756
26940,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,9.35,02/26/2015,GNRL,319366451
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,9.18,04/01/2015,GNRL,330502805
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,9.13,11/13/2015,GNRL,331099897
26940,GNRL,"Astellas Pharma US Inc",IL,100000000137,9.02,12/10/2013,GNRL,101653972
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,9.01,06/09/2014,GNRL,201838912
26940,GNRL,"Novo Nordisk Inc",NJ,100000000144,8.90,02/24/2014,GNRL,161014756
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,8.86,08/05/2014,GNRL,202034062
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,8.83,06/03/2014,GNRL,201757046
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,8.82,04/17/2014,GNRL,201581788
26940,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,8.79,09/29/2014,GNRL,198549056
26940,GNRL,"Lilly USA, LLC",IN,100000000066,8.79,01/26/2015,GNRL,267993210
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,8.75,10/23/2015,GNRL,330989835
26940,GNRL,"Pfizer Inc.",NY,100000000286,8.74,10/21/2014,GNRL,205578221
26940,GNRL,"Pfizer Inc.",NY,100000000286,8.74,09/18/2015,GNRL,323117595
26940,GNRL,"Pfizer Inc.",NY,100000000286,8.72,12/03/2014,GNRL,205873434
26940,GNRL,"Pfizer Inc.",NY,100000000286,8.66,05/12/2015,GNRL,322776828
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,8.66,09/28/2015,GNRL,330922917
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,8.57,04/25/2014,GNRL,147789030
26940,GNRL,"Takeda Pharmaceuticals America, Inc.",IL,100000000339,8.50,03/20/2015,GNRL,337032238
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,8.46,06/17/2014,GNRL,202775082
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,8.40,08/19/2014,GNRL,201983728
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,8.35,11/04/2015,GNRL,331025423
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,8.25,05/20/2014,GNRL,147789025
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,8.19,10/16/2014,GNRL,202329927
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,8.18,12/27/2013,GNRL,100452554
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,8.08,06/02/2015,GNRL,330556933
26940,GNRL,"Lilly USA, LLC",IN,100000000066,7.80,11/02/2015,GNRL,267993216
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,7.72,09/23/2015,GNRL,330904597
26940,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,7.70,04/30/2014,GNRL,196603852
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,7.68,08/14/2015,GNRL,330764293
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,7.57,08/19/2015,GNRL,330783499
26940,GNRL,"Actavis Pharma Inc",NJ,100000010642,7.54,10/14/2015,GNRL,339065500
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,7.50,04/17/2015,GNRL,330422177
26940,GNRL,"Pfizer Inc.",NY,100000000286,7.44,10/15/2014,GNRL,207175312
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,7.21,06/25/2014,GNRL,147789020
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,6.94,02/19/2014,GNRL,201285066
26940,GNRL,"Novo Nordisk Inc",NJ,100000000144,6.84,08/10/2015,GNRL,269912972
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,6.80,10/01/2014,GNRL,202144292
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,6.79,04/28/2014,GNRL,201567978
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,6.73,10/10/2013,GNRL,100452568
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,6.65,07/16/2014,GNRL,147789016
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,6.35,02/18/2014,GNRL,147789038
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,6.14,05/15/2014,GNRL,201708346
26940,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,6.00,12/24/2015,GNRL,319478960
26940,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,5.62,07/15/2014,GNRL,198549068
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,5.38,08/11/2014,GNRL,147789088
26940,GNRL,"Astellas Pharma US Inc",IL,100000000137,5.37,10/17/2013,GNRL,101658662
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,5.37,09/23/2014,GNRL,147789104
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,5.37,07/31/2014,GNRL,147789012
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,5.08,03/03/2015,GNRL,330356075
26940,GNRL,"Pfizer Inc.",NY,100000000286,5.00,09/03/2014,GNRL,206135598
26940,GNRL,"Pfizer Inc.",NY,100000000286,5.00,08/12/2014,GNRL,205973302
26940,GNRL,"Pfizer Inc.",NY,100000000286,5.00,10/02/2014,GNRL,205949170
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,4.93,05/28/2014,GNRL,201757856
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,4.69,10/24/2013,GNRL,100452552
26940,GNRL,"Novo Nordisk Inc",NJ,100000000144,4.40,10/21/2015,GNRL,270047644
26940,GNRL,"Pfizer Inc.",NY,100000000286,4.30,04/18/2014,GNRL,207153220
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,4.22,10/29/2014,GNRL,202319214
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,4.21,06/24/2014,GNRL,201823706
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,4.19,09/12/2013,GNRL,100452548
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,4.09,07/02/2015,GNRL,330652549
26940,GNRL,"Novo Nordisk Inc",NJ,100000000144,4.00,12/15/2015,GNRL,270129604
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,3.99,04/17/2015,GNRL,330502291
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,3.93,09/05/2014,GNRL,202141358
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,3.91,10/02/2015,GNRL,331026461
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,3.88,04/04/2014,GNRL,201450272
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,3.73,09/19/2014,GNRL,202153968
26940,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,3.44,09/23/2015,GNRL,319807418
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,3.42,02/07/2014,GNRL,201286310
26940,GNRL,"Novo Nordisk Inc",NJ,100000000144,3.34,09/09/2015,GNRL,270011134
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,3.32,01/21/2014,GNRL,147789084
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,3.31,08/08/2014,GNRL,202026650
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,3.22,12/27/2013,GNRL,100452566
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,3.18,01/23/2014,GNRL,147789080
26940,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,3.14,12/15/2015,GNRL,275455540
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,3.12,05/02/2014,GNRL,201580362
26940,GNRL,"Novo Nordisk Inc",NJ,100000000144,3.09,09/03/2015,GNRL,269956882
26940,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,3.00,09/03/2015,GNRL,319564312
26940,GNRL,"SANOFI-AVENTIS U.S. LLC",NJ,100000000076,3.00,10/22/2015,GNRL,318777370
26940,GNRL,"Novo Nordisk Inc",NJ,100000000144,2.86,07/17/2014,GNRL,161801625
26940,GNRL,"Novo Nordisk Inc",NJ,100000000144,2.80,09/14/2015,GNRL,269984104
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,2.75,01/10/2014,GNRL,201065480
26940,GNRL,"Actavis Pharma Inc",NJ,100000010642,2.74,03/19/2015,GNRL,338929508
26940,GNRL,"Pfizer Inc.",NY,100000000286,2.62,07/11/2014,GNRL,205564808
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,2.56,12/11/2015,GNRL,331149417
26940,GNRL,"Pfizer Inc.",NY,100000000286,2.43,06/26/2014,GNRL,207265200
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,2.30,08/07/2015,GNRL,330806933
26940,GNRL,"Pfizer Inc.",NY,100000000286,2.29,11/17/2014,GNRL,206067968
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,2.20,02/18/2014,GNRL,147789072
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,1.83,03/19/2014,GNRL,147789050
26940,GNRL,"Pfizer Inc.",NY,100000000286,1.75,11/06/2015,GNRL,322472928
26940,GNRL,"Merck Sharp & Dohme Corporation",NJ,100000000053,1.74,01/09/2015,GNRL,330158139
26940,GNRL,"Janssen Pharmaceuticals, Inc",NJ,100000000232,1.70,08/11/2015,GNRL,275455528
26940,GNRL,"Pfizer Inc.",NY,100000000286,1.61,05/12/2015,GNRL,323182618
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,1.60,10/18/2013,GNRL,100452546
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,1.58,08/07/2013,GNRL,100452550
26940,GNRL,"Pfizer Inc.",NY,100000000286,1.55,11/04/2015,GNRL,323894150
26940,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.50,12/18/2014,GNRL,162350920
26940,GNRL,"Boehringer Ingelheim Pharmaceuticals, Inc.",CT,100000000234,1.48,12/01/2015,GNRL,290716166
26940,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.48,12/07/2015,GNRL,270105756
26940,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,1.36,06/11/2014,GNRL,198549070
26940,GNRL,"Actavis Pharma Inc",NJ,100000010642,1.33,01/14/2015,GNRL,338880094
26940,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,1.32,01/13/2015,GNRL,319366402
26940,GNRL,"Astellas Pharma US Inc",IL,100000000137,1.25,08/29/2013,GNRL,101680150
26940,GNRL,"Pfizer Inc.",NY,100000000286,1.25,11/01/2015,GNRL,323964076
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,1.22,09/18/2013,GNRL,100452544
26940,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,1.22,08/17/2015,GNRL,319366590
26940,GNRL,"Astellas Pharma US Inc",IL,100000000137,1.17,12/10/2013,GNRL,101653954
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,1.17,09/19/2014,GNRL,147789128
26940,GNRL,"Pfizer Inc.",NY,100000000286,1.16,09/01/2015,GNRL,323818048
26940,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,1.14,05/19/2015,GNRL,319366510
26940,GNRL,"Novo Nordisk Inc",NJ,100000000144,1.07,05/29/2015,GNRL,269757718
26940,GNRL,"Pfizer Inc.",NY,100000000286,1.00,09/20/2015,GNRL,323581944
26940,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,0.99,12/17/2014,GNRL,198549038
26940,GNRL,"FOREST PHARMACEUTICALS, INC.",NJ,100000005529,0.92,09/08/2014,GNRL,147789122
26940,GNRL,"Pfizer Inc.",NY,100000000286,0.91,04/03/2014,GNRL,206778398
26940,GNRL,"Actavis Pharma Inc",NJ,100000010642,0.89,08/05/2015,GNRL,338871794
26940,GNRL,"Astellas Pharma US Inc",IL,100000000137,0.85,11/06/2013,GNRL,101668958
26940,GNRL,"Pfizer Inc.",NY,100000000286,0.76,03/06/2015,GNRL,323461270
26940,GNRL,"Novo Nordisk Inc",NJ,100000000144,0.57,02/24/2014,GNRL,161014760
26940,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,0.57,10/13/2015,GNRL,319366610
26940,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,0.50,12/02/2014,GNRL,198549042
26940,GNRL,"GlaxoSmithKline, LLC.",NC,100000005449,0.50,12/11/2015,GNRL,319366699
26940,GNRL,"Lilly USA, LLC",IN,100000000066,0.47,11/19/2015,GNRL,267993220
26940,GNRL,"Pfizer Inc.",NY,100000000286,0.45,10/15/2014,GNRL,205543818
26940,GNRL,"Pfizer Inc.",NY,100000000286,0.44,07/23/2014,GNRL,206521556
26940,GNRL,"Actavis Pharma Inc",NJ,100000010642,0.37,11/11/2015,GNRL,338858368
26940,GNRL,"Novo Nordisk Inc",NJ,100000000144,0.33,11/06/2015,GNRL,270099902
